Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study

International Journal of Urology

Volumn 20, Issue 6, 2013, Pages 585-592

  Steffens, Sandra ^a   Ringe, Kristina I ^a   Schroeer, Katharina ^b   Lehmann, Rieke ^a   Rustemeier, Julia ^c   Wegener, Gerd ^a   Schrader, Mark ^b   Hofmann, Rainer ^c   Kuczyk, Markus A ^a   Schrader, Andres J ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Body mass index; Body surface area; Obesity; Prognosis; Renal cell carcinoma; Risk factors; Visceral fat

Indexed keywords

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY SURFACE; BODY WEIGHT; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRAABDOMINAL FAT; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY (TOPIC); OBESITY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR INVASION;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; MULTICENTER STUDIES AS TOPIC; OVERWEIGHT;

EID: 84878631404     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12000     Document Type: Article

References (35)

1. Schrader AJ, Hofmann R. Metastatic renal cell carcinoma: recent advances and current therapeutic options. Anticancer Drugs 2008; 9: 25-245.
2. GEKID-Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.: Krebs in Deutschland. [Cited 1 Apr 2012.] Available from URL: http://www.GEKID.de
3. Appel K, Rohde D. Risk factors for renal carcinoma in older women. Aktuelle Urol. 2004; 35: 357-359.
4. Wolk A, Lindblad P, Adami HO. Nutrition and renal cell cancer. Cancer Causes Control 1996; 7: 5-18.
5. Moyad MA. Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin. Urol. Oncol. 2001; 19: 270-279.
6. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N. Engl. J. Med. 2000; 343: 1305-1311.
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-1638.
8. Pischon T, Lahmann PH, Boeing H etal. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 2006; 118: 728-738.
9. Waalkes S, Merseburger AS, Kramer MW etal. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control 2010; 21: 1905-1910.
10. Waalkes S, Eggers H, Rustemeier J etal. Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer. Urologe A 2011; 50: 1118-1124.
11. Yu ML, Asal NR, Geyer JR. Later recurrence and longer survival among obese patients with renal cell carcinoma. Cancer 1991; 68: 1648-1655.
12. Kamat AM, Shock RP, Naya Y, Rosser CJ, Slaton JW, Pisters LL. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology 2004; 63: 46-50.
13. Schips L, Lipsky K, Zigeuner R etal. Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients. J. Surg. Oncol. 2004; 88: 57-61.
14. Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology 2006; 68: 741-746.
15. Schrader AJ, Rustemeier J, Rustemeier JC etal. Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma. J. Cancer Res. Clin. Oncol. 2009; 135: 1693-1699.
16. Waalkes S, Merseburger AS, Kramer MW etal. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control 2010; 21: 1905-1910.
17. Haferkamp A, Pritsch M, Bedke J etal. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy. BJU Int. 2008; 101: 1243-1246.
18. Donat SM, Salzhauer EW, Mitra N, Yanke BV, Snyder ME, Russo P. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma. J. Urol. 2006; 175: 46-52.
19. Ather MH, Nazim SM. Impact of Charlson's comorbidity index on overall survival following tumor nephrectomy for renal cell carcinoma. Int. Urol. Nephrol. 2010; 42: 299-303.
20. Brookman-May S, Kendel F, Hoschke B etal. Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma. Scand. J. Urol. Nephrol. 2011; 45: 5-14.
21. Mosteller RD. Simplified calculation of body-surface area. N. Engl. J. Med. 1987; 317: 1098.
22. Heaf JG. The origin of the 1.73-m2 body surface area normalization: problems and implications. Clin. Physiol. Funct. Imaging 2007; 27: 135-137.
23. Health-Statistics. Key Data on Health 2002. Office for Official Publications of the European Community, Luxembourg, 2002.
24. Yoshizumi T, Nakamura T, Yamane M etal. Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283-286.
25. Ladoire S, Bonnetain F, Gauthier M etal. Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents. Oncologist 2011; 16: 71-81.
26. Steffens S, Grunwald V, Ringe KI etal. Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy? Oncologist 2011; 16: 1565-1571.
27. Dhote R, Pellicercoeuret N, Thionunn B, Vidaltrecan DG. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int. 2000; 86: 20-27.
28. Wolk A, Gridley G, Svensson M etal. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001; 12: 13-21.
29. Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y. Association of obesity and cancer risk in Canada. Am. J. Epidemiol. 2004; 159: 259-268.
30. Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int. 2009; 6: 16-20.
31. Choueiri TK, Xie W, Kollmannsberger CK etal. The impact of body mass index (BMI) and body surface area (BSA) on treatment outcome to vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma: results from a large international collaboration. ASCO Annual Meeting. 2010: abstract 4524.
32. Kirkali Z. The motion: open partial nephrectomy is the standard of care for small resectable solid renal masses. Eur. Urol. 2007; 51: 561-562.
33. Olbert P, Hegele A, Schrader AJ. DGU, EAU, AUA, ASCO 2006 - Relevantes und Innovatives für die Urologische Onkologie in Klinik und Praxis. Aktuelle Urol. 2006; 37: 401-410.
34. Asal NR, Risser DR, Kadamani S, Geyer JR, Lee ET, Cherng N. Risk factors in renal cell carcinoma: I. Methodology, demographics, tobacco, beverage use, and obesity. Cancer Detect. Prev. 1988; 11: 359-377.
35. Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J. Natl. Cancer Inst. 1986; 77: 351-356.